Floatz logo

Therapeutic Asset Ratings

2,003 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Bms-907351
Ovarian Carcinoma
M.D. Anderson Cancer CenterP2BB (66)
FILGRASTIM
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
M.D. Anderson Cancer CenterP2BB (66)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Therapy-Related Myelodysplastic Syndrome
M.D. Anderson Cancer CenterP2BB (66)
Venetoclax
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
M.D. Anderson Cancer CenterP2BB (66)
Pegloticase
Cancer
M.D. Anderson Cancer CenterP4BB (65)
ETOPOSIDE
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
M.D. Anderson Cancer CenterP3BB (65)
FENTANYL
Cancer
M.D. Anderson Cancer CenterP3BB (65)
Fludarabine
Hodgkins Lymphoma
M.D. Anderson Cancer CenterP3BB (65)
FULVESTRANT
Invasive Lobular Breast Carcinoma
M.D. Anderson Cancer CenterP3BB (65)
Inno-206
Philadelphia Chromosome Positive
M.D. Anderson Cancer CenterP3BB (65)
METHOTREXATE
Philadelphia Chromosome Positive
M.D. Anderson Cancer CenterP3BB (65)
Pembrolizumab
Adenocarcinoma
M.D. Anderson Cancer CenterP3BB (65)
Sonrotoclax
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
M.D. Anderson Cancer CenterP3BB (65)
Cediranib
Her2-Receptor Negative Breast Cancer
M.D. Anderson Cancer CenterP2BB (65)
Cladribine
Myeloproliferative Neoplasm
M.D. Anderson Cancer CenterP2BB (65)
DEXAMETHASONE
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
M.D. Anderson Cancer CenterP2BB (65)
Epirubicin
Cancer Of Unknown Primary Site
M.D. Anderson Cancer CenterP2BB (65)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Acute Biphenotypic Leukemia
M.D. Anderson Cancer CenterP2BB (65)
Nivolumab
Hematopoietic And Lymphoid Cell Neoplasm
M.D. Anderson Cancer CenterP2BB (65)
Nivolumab
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
M.D. Anderson Cancer CenterP2BB (65)
Nivolumab
Refractory Chronic Lymphocytic Leukemia
M.D. Anderson Cancer CenterP2BB (65)
Ponatinib
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
M.D. Anderson Cancer CenterP2BB (65)
Vorinostat
Burkitt Lymphoma
M.D. Anderson Cancer CenterP2BB (65)
Alpelisib
Breast Cancer
M.D. Anderson Cancer CenterP4BB (64)
Astx727
Acute Myeloid Leukemia
M.D. Anderson Cancer CenterP3BB (64)
Showing 126 to 150 of 2,003 assets
PreviousPage 6 of 81Next